Skip to main content
Top
Published in: BMC Nephrology 1/2006

Open Access 01-12-2006 | Research article

Anemia and chronic kidney disease are associated with poor outcomes in heart failure patients

Authors: Jean-Christophe Luthi, W Dana Flanders, Michel Burnier, Bernard Burnand, William M McClellan

Published in: BMC Nephrology | Issue 1/2006

Login to get access

Abstract

Background

Chronic kidney disease (CKD) has been linked to higher heart failure (HF) risk. Anemia is a common consequence of CKD, and recent evidence suggests that anemia is a risk factor for HF. The purpose of this study was to examine among patients with HF, the association between CKD, anemia and inhospital mortality and early readmission.

Methods

We performed a retrospective cohort study in two Swiss university hospitals. Subjects were selected based the presence of ICD-10 HF codes in 1999. We recorded demographic characteristics and risk factors for HF. CKD was defined as a serum creatinine ≥ 124 956;mol/L for women and ≥ 133 μmol/L for men. The main outcome measures were inhospital mortality and thirty-day readmissions.

Results

Among 955 eligible patients hospitalized with heart failure, 23.0% had CKD. Twenty percent and 6.1% of individuals with and without CKD, respectively, died at the hospital (p < 0.0001). Overall, after adjustment for other patient factors, creatinine and hemoglobin were associated with an increased risk of death at the hospital, and hemoglobin was related to early readmission.

Conclusion

Both CKD and anemia are frequent among older patients with heart failure and are predictors of adverse outcomes, independent of other known risk factors for heart failure.
Literature
1.
go back to reference Williams JF, Bristow MR, Fowler MB, Francis GS, Garson A, Gersh BJ, Hammer DF: Guidelines for the Evaluation and Management of Heart Failure: Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). J Am Coll Cardiol. 1995, 26: 1376-1398. 10.1016/0735-1097(95)00378-9.CrossRef Williams JF, Bristow MR, Fowler MB, Francis GS, Garson A, Gersh BJ, Hammer DF: Guidelines for the Evaluation and Management of Heart Failure: Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). J Am Coll Cardiol. 1995, 26: 1376-1398. 10.1016/0735-1097(95)00378-9.CrossRef
2.
go back to reference Remme WJ, Swedberg K, Task Force for the Diagnosis and Treatment of Chronic Heart Failure European Society of Cardiology: Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 2001, 22: 1527-1560. 10.1053/euhj.2001.2783.CrossRefPubMed Remme WJ, Swedberg K, Task Force for the Diagnosis and Treatment of Chronic Heart Failure European Society of Cardiology: Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 2001, 22: 1527-1560. 10.1053/euhj.2001.2783.CrossRefPubMed
3.
go back to reference Bailly AS, Periat M Le: coût du petit débit cardiaque: une approche médicométrique. Med et Hyg. 1997, 55: 1155-9. Bailly AS, Periat M Le: coût du petit débit cardiaque: une approche médicométrique. Med et Hyg. 1997, 55: 1155-9.
4.
go back to reference NIH Consensus Statement: Consensus Development Conference Panel. Morbidity and Mortality of Renal Dialysis. Ann Intern Med. 1994, 121: 62-67.CrossRef NIH Consensus Statement: Consensus Development Conference Panel. Morbidity and Mortality of Renal Dialysis. Ann Intern Med. 1994, 121: 62-67.CrossRef
5.
go back to reference Rossert JA, Wauters JP: Recommendation for the screening and management of patients with chronic kidney disease. Nephrol Dial Transplant. 2002, 17: 19-28. 10.1093/ndt/17.suppl_1.19.CrossRefPubMed Rossert JA, Wauters JP: Recommendation for the screening and management of patients with chronic kidney disease. Nephrol Dial Transplant. 2002, 17: 19-28. 10.1093/ndt/17.suppl_1.19.CrossRefPubMed
6.
go back to reference US Renal Data System 2001 (USRDS 2001) Annual Data Report. National Institute of Diabetes and Digestive and Kidney Diseases. 2001 US Renal Data System 2001 (USRDS 2001) Annual Data Report. National Institute of Diabetes and Digestive and Kidney Diseases. 2001
7.
go back to reference Cleland JGF, Khand A, Clark AL: The Heart Failure Epidemic: Exactly how big is-it?. Eur Heart J. 2001, 22: 623-626. 10.1053/euhj.2000.2493.CrossRefPubMed Cleland JGF, Khand A, Clark AL: The Heart Failure Epidemic: Exactly how big is-it?. Eur Heart J. 2001, 22: 623-626. 10.1053/euhj.2000.2493.CrossRefPubMed
8.
go back to reference Petrie MC, Berry C, Stewart S, McMeray JJV: Failing Aging Hearts. Eur Heart J. 2001, 22: 1978-1990. 10.1053/euhj.2000.2558.CrossRefPubMed Petrie MC, Berry C, Stewart S, McMeray JJV: Failing Aging Hearts. Eur Heart J. 2001, 22: 1978-1990. 10.1053/euhj.2000.2558.CrossRefPubMed
9.
go back to reference Miller LW, Nussov ED: Epidemiology of Heart Failure. Cardiologic Clinics. 2001, 19: 547-555. 10.1016/S0733-8651(05)70242-3.CrossRef Miller LW, Nussov ED: Epidemiology of Heart Failure. Cardiologic Clinics. 2001, 19: 547-555. 10.1016/S0733-8651(05)70242-3.CrossRef
10.
go back to reference Erslev AJ, Besarab A: Erythropoietin in Pathogenesis and Treatment of Anemia of Chronic Renal Failure. Kid Intern. 1997, 51: 622-130.CrossRef Erslev AJ, Besarab A: Erythropoietin in Pathogenesis and Treatment of Anemia of Chronic Renal Failure. Kid Intern. 1997, 51: 622-130.CrossRef
11.
go back to reference Valderrabano F: Anemia Management in Chronic Kidney Disease Patients: an Overview of Current Clinical Practice. Nephrol Dial Transplant. 2002, 17: 13-18. 10.1093/ndt/17.suppl_1.13.CrossRefPubMed Valderrabano F: Anemia Management in Chronic Kidney Disease Patients: an Overview of Current Clinical Practice. Nephrol Dial Transplant. 2002, 17: 13-18. 10.1093/ndt/17.suppl_1.13.CrossRefPubMed
12.
go back to reference Ezekowitz JA, McAlister FA, Armstrong PW: Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes. Insights From a Cohort of 12'065 Patients With New-Onset Heart Failure. Circulation. 2003, 107: 223-225. 10.1161/01.CIR.0000052622.51963.FC.CrossRefPubMed Ezekowitz JA, McAlister FA, Armstrong PW: Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes. Insights From a Cohort of 12'065 Patients With New-Onset Heart Failure. Circulation. 2003, 107: 223-225. 10.1161/01.CIR.0000052622.51963.FC.CrossRefPubMed
13.
go back to reference Tanner H, Moschovitis G, Kuster GM, Hullin R, Pfiffner D, Hess OM, Mohacsi P: The prevalence of anemia in chronic heart failure. International Journal of Cardiology. 2002, 86: 115-121. 10.1016/S0167-5273(02)00273-5.CrossRefPubMed Tanner H, Moschovitis G, Kuster GM, Hullin R, Pfiffner D, Hess OM, Mohacsi P: The prevalence of anemia in chronic heart failure. International Journal of Cardiology. 2002, 86: 115-121. 10.1016/S0167-5273(02)00273-5.CrossRefPubMed
14.
go back to reference Felker GM, Gattis WA, Leimberger JD, Adams KF, Cuffe MS, Gheorghiade M, O'Connor CM: Usefulness of Anemia as a Predictor of Death and Re-Hospitalization in Patients with Decompensate Heart Failure. Am J Cardiol. 2003, 92: 625-628. 10.1016/S0002-9149(03)00740-9.CrossRefPubMed Felker GM, Gattis WA, Leimberger JD, Adams KF, Cuffe MS, Gheorghiade M, O'Connor CM: Usefulness of Anemia as a Predictor of Death and Re-Hospitalization in Patients with Decompensate Heart Failure. Am J Cardiol. 2003, 92: 625-628. 10.1016/S0002-9149(03)00740-9.CrossRefPubMed
15.
go back to reference Kosiborod M, Smith GL, Radford MJ, Fooy JM, Krumholz HM: The Prognostic Importance of Anemia in Patients with Heart Failure. Am J Med. 2003, 114: 112-119. 10.1016/S0002-9343(02)01498-5.CrossRefPubMed Kosiborod M, Smith GL, Radford MJ, Fooy JM, Krumholz HM: The Prognostic Importance of Anemia in Patients with Heart Failure. Am J Med. 2003, 114: 112-119. 10.1016/S0002-9343(02)01498-5.CrossRefPubMed
16.
go back to reference Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J: Anemia is Associated with Worth Symptoms, Greater in Permanent Functional Capacity and Significant Increase in Mortality in Patients with Advanced Heart Failure. J Am Coll Cardiol. 2002, 39: 1780-1786. 10.1016/S0735-1097(02)01854-5.CrossRefPubMed Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J: Anemia is Associated with Worth Symptoms, Greater in Permanent Functional Capacity and Significant Increase in Mortality in Patients with Advanced Heart Failure. J Am Coll Cardiol. 2002, 39: 1780-1786. 10.1016/S0735-1097(02)01854-5.CrossRefPubMed
17.
go back to reference Mozaffarian D, Nye R, Levi WC: Anemia Predicts Mortality in Severe Heart Failure. The Prospective Randomized Am Iodipin Survival Evaluation (PRAISE). J Am Coll Cardiol. 2003, 41: 1933-1939. 10.1016/S0735-1097(03)00425-X.CrossRefPubMed Mozaffarian D, Nye R, Levi WC: Anemia Predicts Mortality in Severe Heart Failure. The Prospective Randomized Am Iodipin Survival Evaluation (PRAISE). J Am Coll Cardiol. 2003, 41: 1933-1939. 10.1016/S0735-1097(03)00425-X.CrossRefPubMed
18.
go back to reference Nordyke RJ, Kim JJ, Goldberg GA, Vendiola R, Batra D, McCamish M, Thomasson JW: Impact of Anemia on Hospitalization Time, Charges, and Mortality in Patients with Heart Failure. Value in Health. 2004, 7: 464-471. 10.1111/j.1524-4733.2004.74009.x.CrossRefPubMed Nordyke RJ, Kim JJ, Goldberg GA, Vendiola R, Batra D, McCamish M, Thomasson JW: Impact of Anemia on Hospitalization Time, Charges, and Mortality in Patients with Heart Failure. Value in Health. 2004, 7: 464-471. 10.1111/j.1524-4733.2004.74009.x.CrossRefPubMed
19.
go back to reference Anand I, McMurray JJ, Whitmore J, Warren M, Pham A, McCamish MA, Burton PB: Anemia and its Relationship to Clinical Outcome in Heart Failure. Circulation. 2004, 110: 149-154. 10.1161/01.CIR.0000134279.79571.73.CrossRefPubMed Anand I, McMurray JJ, Whitmore J, Warren M, Pham A, McCamish MA, Burton PB: Anemia and its Relationship to Clinical Outcome in Heart Failure. Circulation. 2004, 110: 149-154. 10.1161/01.CIR.0000134279.79571.73.CrossRefPubMed
20.
go back to reference Ryan E, Devlin M, Prendiville TE, Ledwidge M, McDonald K: The prevalence and natural history of anaemia in an optimally treated heart failure population. Br J Cardiol. 2004, 11: 369-375. Ryan E, Devlin M, Prendiville TE, Ledwidge M, McDonald K: The prevalence and natural history of anaemia in an optimally treated heart failure population. Br J Cardiol. 2004, 11: 369-375.
21.
go back to reference Gregory DD, Sarnak MJ, Konstam MA, Pereira B, Salem D: Impact of Chronic Kidney Disease and Anemia on Hospitalization Expense in Patients With Left Ventricular Dysfunction. Am J Cardiol. 2003, 92: 1300-1305. 10.1016/j.amjcard.2003.08.011.CrossRefPubMed Gregory DD, Sarnak MJ, Konstam MA, Pereira B, Salem D: Impact of Chronic Kidney Disease and Anemia on Hospitalization Expense in Patients With Left Ventricular Dysfunction. Am J Cardiol. 2003, 92: 1300-1305. 10.1016/j.amjcard.2003.08.011.CrossRefPubMed
22.
go back to reference Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ: Reduced Kidney Function and Anemia as Risk Factors for Mortality in Patients with Left Ventricular Dysfunction. J Am Coll Cardiol. 2001, 38: 955-962. 10.1016/S0735-1097(01)01470-X.CrossRefPubMed Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ: Reduced Kidney Function and Anemia as Risk Factors for Mortality in Patients with Left Ventricular Dysfunction. J Am Coll Cardiol. 2001, 38: 955-962. 10.1016/S0735-1097(01)01470-X.CrossRefPubMed
23.
go back to reference McClellan WM, Flanders WD, Langston RD, Jurkovitz EC, Presley R: Anemia in Renal Insufficiency are Independent in Risk Factors for Death among Patients with Congestive Heart Failure admitted to Community Hospitals: A Population-based Study. J Am Soc Nephrol. 2002, 13: 1928-1936. 10.1097/01.ASN.0000018409.45834.FA.CrossRefPubMed McClellan WM, Flanders WD, Langston RD, Jurkovitz EC, Presley R: Anemia in Renal Insufficiency are Independent in Risk Factors for Death among Patients with Congestive Heart Failure admitted to Community Hospitals: A Population-based Study. J Am Soc Nephrol. 2002, 13: 1928-1936. 10.1097/01.ASN.0000018409.45834.FA.CrossRefPubMed
24.
go back to reference Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbity index for use with ICD-9 CM administrative databases. J Clin Epidemiol. 1992, 45: 613-619. 10.1016/0895-4356(92)90133-8.CrossRefPubMed Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbity index for use with ICD-9 CM administrative databases. J Clin Epidemiol. 1992, 45: 613-619. 10.1016/0895-4356(92)90133-8.CrossRefPubMed
25.
go back to reference Herzog CA, Li S, Collins AJ: The impact of congestive heart failure (CHF), chronic kidney disease (CKD), and anemia on survival in the Medicare population. Circulation. 2002, 106 (suppl): 471-2. Herzog CA, Li S, Collins AJ: The impact of congestive heart failure (CHF), chronic kidney disease (CKD), and anemia on survival in the Medicare population. Circulation. 2002, 106 (suppl): 471-2.
26.
go back to reference Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, Brosh D, Laniado S, Schwartz D, Yachnin T, Shapira I, Gavish D, Baruch R, Koifman B, Kaplan C, Steinbruch S, Iaina A: The Use of Subcutaneous Erythropoietin and Intravenous Iron for the Treatment of Anemia of Severe, Resistant Congestive Heart Failure Improved Cardiac and Renal Function and Functional Cardiac Class, And Markedly Reduces Hospitalization. J Am Coll Cardiol. 2000, 35: 1737-1744. 10.1016/S0735-1097(00)00613-6.CrossRefPubMed Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, Brosh D, Laniado S, Schwartz D, Yachnin T, Shapira I, Gavish D, Baruch R, Koifman B, Kaplan C, Steinbruch S, Iaina A: The Use of Subcutaneous Erythropoietin and Intravenous Iron for the Treatment of Anemia of Severe, Resistant Congestive Heart Failure Improved Cardiac and Renal Function and Functional Cardiac Class, And Markedly Reduces Hospitalization. J Am Coll Cardiol. 2000, 35: 1737-1744. 10.1016/S0735-1097(00)00613-6.CrossRefPubMed
27.
go back to reference National Kidney Foundation K/DOQI clinical practice guidelines for anemia of chronic kidney disease: update 2000. Am J Kidney Dis. 2001, 37 (suppl 1): S182-S238. National Kidney Foundation K/DOQI clinical practice guidelines for anemia of chronic kidney disease: update 2000. Am J Kidney Dis. 2001, 37 (suppl 1): S182-S238.
28.
go back to reference Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW: The Prognostic Implications of Renal Insufficiency in Asymptomatic Patients with Left Ventricular Systolic Dysfunction. J Am Coll Cardiol. 2000, 35: 681-689. 10.1016/S0735-1097(99)00608-7.CrossRefPubMed Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW: The Prognostic Implications of Renal Insufficiency in Asymptomatic Patients with Left Ventricular Systolic Dysfunction. J Am Coll Cardiol. 2000, 35: 681-689. 10.1016/S0735-1097(99)00608-7.CrossRefPubMed
29.
go back to reference Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, Hampton JR, van Veldhuisen DJ: Renal Function, Neuro-hormonal Activation, and Survival in Patients with Chronic Heart Failure. Circulation. 2000, 102: 203-210.CrossRefPubMed Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, Hampton JR, van Veldhuisen DJ: Renal Function, Neuro-hormonal Activation, and Survival in Patients with Chronic Heart Failure. Circulation. 2000, 102: 203-210.CrossRefPubMed
30.
go back to reference Crommie N, Lee C, Struthers AD: Anemia in Chronic Heart Failure: What is its frequency in the UK and its underlining causes?. Heart. 2002, 87: 377-378. 10.1136/heart.87.4.377.CrossRef Crommie N, Lee C, Struthers AD: Anemia in Chronic Heart Failure: What is its frequency in the UK and its underlining causes?. Heart. 2002, 87: 377-378. 10.1136/heart.87.4.377.CrossRef
31.
go back to reference Coletta AP, Niktin N, Clarc AL, Cleland IJGF: Clinical Trials Updates from the American Heart Association Meeting: PROSPER, DIAL, Home Care Monitoring Trials, Immuno-Modulation Therapy, COMPANION and Anemia in Heart Failure. European Journal of Heart Failure. 2003, 5: 95-99. 10.1016/S1388-9842(02)00249-0.CrossRefPubMed Coletta AP, Niktin N, Clarc AL, Cleland IJGF: Clinical Trials Updates from the American Heart Association Meeting: PROSPER, DIAL, Home Care Monitoring Trials, Immuno-Modulation Therapy, COMPANION and Anemia in Heart Failure. European Journal of Heart Failure. 2003, 5: 95-99. 10.1016/S1388-9842(02)00249-0.CrossRefPubMed
32.
go back to reference Silverberg DS, Wexler D, Blum M, Tchebiner J, Sheps D, Keren G, Schwartz D, Baruch R, Yachnin T, Shaked M, Zubkov A, Steinbruch S, Iaina A: The Correction of Anemia in Severe Resistant Heart Failure with Erythropoietin in Intravenous Iron Prevents the Progression of Both the Heart and the Renal Failure and Markedly Reduces Hospitalization. Clinical Nephrology. 2002, 58 (suppl 1): S37-S45.PubMed Silverberg DS, Wexler D, Blum M, Tchebiner J, Sheps D, Keren G, Schwartz D, Baruch R, Yachnin T, Shaked M, Zubkov A, Steinbruch S, Iaina A: The Correction of Anemia in Severe Resistant Heart Failure with Erythropoietin in Intravenous Iron Prevents the Progression of Both the Heart and the Renal Failure and Markedly Reduces Hospitalization. Clinical Nephrology. 2002, 58 (suppl 1): S37-S45.PubMed
33.
go back to reference European Best Practice Guidelines for the Management of Anemia in Patients with chronic Renal Failure. Nephrol Dial Transplant. 1999, 14 (suppl 5): 1-50. European Best Practice Guidelines for the Management of Anemia in Patients with chronic Renal Failure. Nephrol Dial Transplant. 1999, 14 (suppl 5): 1-50.
Metadata
Title
Anemia and chronic kidney disease are associated with poor outcomes in heart failure patients
Authors
Jean-Christophe Luthi
W Dana Flanders
Michel Burnier
Bernard Burnand
William M McClellan
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2006
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-7-3

Other articles of this Issue 1/2006

BMC Nephrology 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.